According to Aurobindo Pharma 's latest financial reports the company's current earnings are S$3.52 Billion. In 2023 the company made an earning of S$0.67 Billion, an increase over its 2022 earnings that were of S$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.